Mikhail Blagosklony is a professor at the Roswell Park Cancer Institute in New York, a professor of Oncology to be precise. He joined this institute in 15th April 2009. He is studies cancer and ways to curb aging. Mikhail Blagosklony fields are anti-aging medicine and oncology. His alma mater is Polvo state Medical University of St. Peterburg where he earned MD in internal medicine. He also had a Ph.D. in experimental medicine and cardiology.
Due to his knowledge, he was made an associate professor in 2002 at the New York medical college. He moved on to Ordway research institute where he served and was made a senior scientist.
Blagosklonny formulated a hypothesis about possible roles of TOR signaling in both aging and cancer. He suggested using rapamycin a renowned cancer drug as treatment for life extension or anti-aging. Also as part of his hypothesis, ontogenesis, cell cycle, cellular biology, anti-cancer therapeutics, clinical investigations, zeros in molecular biology, and tumor suppressors.
Mikhail’s research range from clinical investigations to cellular and molecular biology. His research also encompasses biogerontology (underlying mechanism of aging), anti-aging drugs, cancer and targeted cancer therapies that help guard the healthy cell against getting damaged. He is a passionate and relentless advocate for rapamycin research.
He is an associate editor of many publications, including International Journal for Cancer and an American Journal of Pathology. Mikhail sees journals as a great medium of creating awareness and also opening their eyes concerning the things that are happening relating to the medical field. With his journals on cancer so many people have been enlightened about cancer and also how to manage it if diagnosed with the condition. Mikhail is also an editor-in-chief of cell cycle, aging, and Oncotarget. An associate editor of Cancer Biology & Therapy, he also seats in the editorial board of Cell death and differentiation.
He has published numerous papers over 270 in peer-reviewed journals with over 25,000 citations, and this made him have an h-index of 83. Mikhail Blagosklonny skills, achievements, knowledge was earned in this various places he worked, and it made him become an excellent man and a professor in his field.
The scientists, in his field, believe that cancer can be cured and that was why he suggested rapamycin to be used to cure the disease. He also believes that with rapamycin we can have a society free from cancer and aging effects, and that is why he devoted more of his time to research about oncology.
Till date, Mikhail Blagosklonny has written over 300 articles, books, chapters and reviews in his name. His publications are on chemotherapeutic engineering, aging hyperfunction theory, and cell cyclotherapy. He subsequently shares his ideas with the public about cancer and aging. His contributions and ideas on cancer and aging have been integral. Visit classroomvoices.org to read more about Mikhail.
In conclusion, Blagosklonny Mikhail, consistency and hard work has made him a renowned researcher and Oncologist in the world today. With his works and researches on oncology, it has given people the hope to live again. He said his love for humanity and life drove him to his field of study.